30-Oct-2026 17:41:58

ARTEMISMED Q2 : CONS NET PROFIT UP 3.7% AT ₹31.10 CR (YOY), DOWN 1.1% (QOQ). MIX (ON 1ST LOOK)

Revenue up 13.2% at ₹311.04 Cr (YOY), up 8.3% (QOQ). EBITDA up 7.9% at ₹62.89 Cr (YOY); margins 20.2% v 21.2% (YOY), 21.5% (QOQ). PBT up 4.1% at ₹40.98 Cr (YOY), down 3.9% (QOQ).

Artemis Medicare Services Ltd

← Back to feed